The simultaneous use of antibodies based on two differing mechanisms of action leads to a more effective destruction of tumors. This has been demonstrated by a study in animal models by medical oncologists and scientists. Patients who do not respond to current immunotherapy options could benefit most from this new treatment.
Click here for original story, Novel combination of antibodies leads to significant improvement in cancer immunotherapy
Source: ScienceDaily